Endoscopy
Commentary
Which GI Side Effects Should GLP-1 Prescribers Worry About?
Given the various favorable hepatic effects of GLP-1 RAs, it is likely that the composite benefit on MASLD is multifactorial.
Perspectives
GLP-1 Receptor Agonists in Endoscopy
In this issue of Perspectives, experts debate the cessation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) prior to endoscopy.
From the AGA Journals
Autonomous AI Outperforms Humans in Optical Diagnosis of Colorectal Polyps
Autonomous AI may one day replace histologic assessment of diminutive polyps.
Supplements
Gastroenterology Data Trends 2024
Article
Simulation-Based Training in Endoscopy: Benefits and Challenges
Conference Coverage
Green Initiative Reduces Endoscopic Waste During Colonoscopies
GI endoscopy generates 85,000 metric tons of carbon dioxide waste annually.
In Focus
Endoscopic Management of Barrett’s Esophagus
Barrett’s esophagus is a precursor to esophageal adenocarcinoma, with rising incidence and poor 5-year survival.
The New Gastroenterologist
May 2024 – ICYMI
Perspectives
Artificial Intelligence in GI and Hepatology
As the global discussion on AI has shown, there are real challenges with adoption, including issues with accuracy, reliability, and privacy.
From the AGA Journals
GLP-1s May Increase Post-Endoscopy Aspiration Pneumonia Risk
Additional studies are needed to understand the optimal drug withholding windows before endoscopies and other procedures.